סינרייז
Country: Iżrael
Lingwa: Ebrajk
Sors: Ministry of Health
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
C - 1 ESTERASE INHIBITOR HUMAN 500 UNITS
Disponibbli minn:
NEOPHARM CURE (2005) LTD
Kodiċi ATC:
B02AB03
Għamla farmaċewtika:
LYOPHILIZED POWDER FOR SOLUTION FOR INJECTION
Rotta amministrattiva:
I.V
Manifatturat minn:
SANQUIN BLOOD SUPPLY FOUNDATION, THE NETHERLANDS
Grupp terapewtiku:
C1-INHIBITOR
Indikazzjonijiet terapewtiċi:
Treatment and pre-procedure prevention of angioedema attacks in adults and adolescents with hereditary angioedema (HAE). Routine prevention of angioedema attacks in adults and adolescents with severe and recurrent attacks of hereditary angioedema (HAE), who are intolerant to or insufficiently protected by oral prevention treatments, or patients who are inadequately managed with repeated acute treatment.
Data ta 'l-awtorizzazzjoni:
2013-08-01
